TheEdgeResearch
Home / Stocks / PRTC

PureTech Health plc (PRTC)

NASDAQ Healthcare Biotechnology
$17.38 ▲ +2.12%
Market Cap
$4.23B
Sector
Healthcare
Industry
Biotechnology
Beta
0.76
52-Wk Range
14.5-19.92
CEO
Robert William Henry Lyne
Country
US
Currency
USD

PureTech Health plc operates in the Biotechnology industry of the Healthcare sector, headquartered in Boston, MA, US. The stock last traded at $17.38, up 2.12% on the session, giving a market capitalisation of $4.23B. On trailing twelve-month figures it carries a trailing P/E of -0.60, a net margin of -2355.5%. Its beta of 0.76 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.60
Price / Sales
910.18
Price / Book
0.13
EV / EBITDA
-42.07
Gross margin
-471.2%
Operating margin
-2115.4%
Net margin
-2355.5%
Return on equity
Debt / equity
0.06
Current ratio
6.59
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
56
IPO date
2020-11-16
Headquarters
Boston, MA, US
About PureTech Health plc

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Comparable companies

PureTech Health plc is most often compared with the following Healthcare names:

CLYMGNTAINBXIVAKROSSLNTARS
More research on PRTC
PRTC technical analysis PRTC TheEdge Score Compare against peers
Open full interactive analysis & DCF →